Skip to main content
ANVS
NYSE Life Sciences

Annovis Q2 Loss Widens to $0.40/Share as R&D Spend Doubles; Cash at $18.7M

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.79
Mkt Cap
$76.15M
52W Low
$1.541
52W High
$5.5
52W Position info
16% above low
Off High info
67% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ANVS sits 16% above its 52-week low of $1.541.

Summary

Annovis reported Q2 2026 results with a net loss of $0.40 per share, up from $0.32 a year ago, as R&D expenses more than doubled to $12.0 million. Cash stands at $18.7 million, down from $19.5 million at year-end 2025, with 42.6 million shares outstanding. The company reiterated that topline data from its fully enrolled Phase 3 Alzheimer's trial is expected in Q1 2027, with a database lock planned for that quarter. Management also promoted Cheng Fang to Chief Scientific Officer and provided updates on open-label extension studies for both Alzheimer's and Parkinson's. The widening loss and modest cash position underscore the company's ongoing reliance on dilutive financing, though the Phase 3 readout remains the primary value driver.

At the time of this announcement, ANVS was trading at $1.79 on NYSE in the Life Sciences sector, with a market capitalization of approximately $76.1M. The 52-week trading range was $1.54 to $5.50. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ANVS - Latest Insights

ANVS
Nov 13, 2026, 4:24 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.940
Real-time Price: $0.9261 info
Change: -$0.0139 (-1%) info
Market Cap: $39.525M info
ANVS
Nov 06, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $0.8799
Real-time Price: $0.9261 info
Change: +$0.0462 (+5%) info
Market Cap: $39.525M info
ANVS
Nov 05, 2026, 8:05 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.8689
Real-time Price: $0.9261 info
Change: +$0.0572 (+7%) info
Market Cap: $39.525M info
ANVS
Nov 04, 2026, 5:01 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.940
Real-time Price: $0.9261 info
Change: -$0.0139 (-1%) info
Market Cap: $39.525M info
ANVS
Nov 04, 2026, 4:07 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.8507
Real-time Price: $0.9261 info
Change: +$0.0754 (+9%) info
Market Cap: $39.525M info